Nasopharyngeal Cancer
FEATURES
avatar
299 clinical trials
avatar
0 cell line models
avatar
0 approved drugs
IMAGE
Nasopharyngeal Cancer
Molecular Synopsis
OVERVIEW
Drugs and clinical candidates

No drugs have received FDA approval for Nasopharyngeal Cancer:

    79 drugs have a clinical trial registered for Nasopharyngeal Cancer.

    1024 compounds have been tested in Nasopharyngeal Cancer (673 <= 500nM potency).

    Sources: cancer.gov, clinicaltrials.gov, ChEMBL.

    Clinical trials
    There are 299 clinical trials for Nasopharyngeal Cancer, 189 of which have one or more drug interventions, 110 with no drug intervention.
    Cell line models

    There are 0 Cell Line Models for Nasopharyngeal Cancer.

    Source: COSMIC
    Cell line models

    Please note the mappings below are based on an imperfect algorithm. If you notice any anomalies please report them to us.

    The following terms have been mapped from clinicaltrials.gov mesh condition terms to Nasopharyngeal Cancer:
    • Nasopharyngeal Neoplasms
    • Nasopharyngeal Carcinoma
    The following terms have been mapped from cancer.gov to Nasopharyngeal Cancer: